Insight Molecular Diagnostics (IMDX) Net Cash Flow Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Net Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -10.07% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -6.97% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 144.76% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 41.14% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 29.81% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -26.81% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 14.18% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 4.49% |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | 54.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.60% |
| Dec 31, 2025 | 11.65% |
| Sep 30, 2025 | 23.73% |
| Jun 30, 2025 | -31.56% |
| Mar 31, 2025 | 51.47% |
| Dec 31, 2024 | 38.94% |
| Sep 30, 2024 | -22.92% |
| Jun 30, 2024 | 31.93% |
| Mar 31, 2024 | -27.54% |
| Dec 31, 2023 | -11.38% |
| Sep 30, 2023 | 18.00% |
| Jun 30, 2023 | 194.00% |
| Mar 31, 2023 | -20.85% |
| Dec 31, 2022 | -64.33% |
| Sep 30, 2022 | 7.94% |
| Jun 30, 2022 | 108.92% |
| Mar 31, 2022 | -35.48% |
| Dec 31, 2021 | -40.53% |
| Sep 30, 2021 | -100.00% |
| Jun 30, 2021 | -74.92% |